Pharmaceuticals

2014-2026 Global Organ Transplantation Immunosuppressive Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-14116133 | Published Date: 07-Nov-2019 | No. of pages: 128

Description

The worldwide market for Organ Transplantation Immunosuppressive Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in

Major Region

s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Janssen Pharmaceuticals, Inc.
Genzyme Corporation（Sanofi SA）
Bristol-Myers Squibb Company
Pfizer, Inc.
F.Hoffmann-La Roche Ltd.
GlaxoSmithKline plc.
Novartis Pharmaceuticals Corporation
Astellas Pharma, Inc.
Veloxis Pharmaceuticals A/S
AbbVie, Inc.

Major Types Covered
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids

Major Applications Covered
Kidney
Bone Marrow
Liver
Heart
Lungs
Others (Intestinal and Multi-visceral Organs)

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…